Literature DB >> 35235150

Gene editing and its applications in biomedicine.

Guanglei Li1, Xiangyang Li1, Songkuan Zhuang2, Liren Wang3, Yifan Zhu3, Yangcan Chen4,5,6, Wen Sun4,6, Zeguang Wu7, Zhuo Zhou7, Jia Chen8, Xingxu Huang9, Jin Wang10, Dali Li11, Wei Li12,13,14,15,16, Haoyi Wang17,18,19, Wensheng Wei20.   

Abstract

The steady progress in genome editing, especially genome editing based on the use of clustered regularly interspaced short palindromic repeats (CRISPR) and programmable nucleases to make precise modifications to genetic material, has provided enormous opportunities to advance biomedical research and promote human health. The application of these technologies in basic biomedical research has yielded significant advances in identifying and studying key molecular targets relevant to human diseases and their treatment. The clinical translation of genome editing techniques offers unprecedented biomedical engineering capabilities in the diagnosis, prevention, and treatment of disease or disability. Here, we provide a general summary of emerging biomedical applications of genome editing, including open challenges. We also summarize the tools of genome editing and the insights derived from their applications, hoping to accelerate new discoveries and therapies in biomedicine.
© 2022. Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  CRISPR; animal model; diagnostics; gene editing; high-throughput functional genomics; therapeutics

Mesh:

Substances:

Year:  2022        PMID: 35235150      PMCID: PMC8889061          DOI: 10.1007/s11427-021-2057-0

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   10.372


  480 in total

1.  Applying CRISPR-Cas12a as a Signal Amplifier to Construct Biosensors for Non-DNA Targets in Ultralow Concentrations.

Authors:  Junjie Li; Shuangshuang Yang; Chen Zuo; Ling Dai; Yongcan Guo; Guoming Xie
Journal:  ACS Sens       Date:  2020-03-20       Impact factor: 7.711

2.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

3.  Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.

Authors:  Reuben Benjamin; Charlotte Graham; Deborah Yallop; Agnieszka Jozwik; Oana C Mirci-Danicar; Giovanna Lucchini; Danielle Pinner; Nitin Jain; Hagop Kantarjian; Nicolas Boissel; Marcela V Maus; Matthew J Frigault; André Baruchel; Mohamad Mohty; Athos Gianella-Borradori; Florence Binlich; Svetlana Balandraud; Fabien Vitry; Elisabeth Thomas; Anne Philippe; Sylvain Fouliard; Sandra Dupouy; Ibtissam Marchiq; Maria Almena-Carrasco; Nicolas Ferry; Sylvain Arnould; Cyril Konto; Paul Veys; Waseem Qasim
Journal:  Lancet       Date:  2020-12-12       Impact factor: 79.321

4.  Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.

Authors:  Akin Akinc; William Querbes; Soma De; June Qin; Maria Frank-Kamenetsky; K Narayanannair Jayaprakash; Muthusamy Jayaraman; Kallanthottathil G Rajeev; William L Cantley; J Robert Dorkin; James S Butler; Liuliang Qin; Timothy Racie; Andrew Sprague; Eugenio Fava; Anja Zeigerer; Michael J Hope; Marino Zerial; Dinah W Y Sah; Kevin Fitzgerald; Mark A Tracy; Muthiah Manoharan; Victor Koteliansky; Antonin de Fougerolles; Martin A Maier
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

5.  Therapeutic base editing of human hematopoietic stem cells.

Authors:  Jing Zeng; Yuxuan Wu; Chunyan Ren; Jasmine Bonanno; Anne H Shen; Devlin Shea; Jason M Gehrke; Kendell Clement; Kevin Luk; Qiuming Yao; Rachel Kim; Scot A Wolfe; John P Manis; Luca Pinello; J Keith Joung; Daniel E Bauer
Journal:  Nat Med       Date:  2020-03-16       Impact factor: 53.440

6.  Breaking the code of DNA binding specificity of TAL-type III effectors.

Authors:  Jens Boch; Heidi Scholze; Sebastian Schornack; Angelika Landgraf; Simone Hahn; Sabine Kay; Thomas Lahaye; Anja Nickstadt; Ulla Bonas
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

7.  Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.

Authors:  Qiurong Ding; Alanna Strong; Kevin M Patel; Sze-Ling Ng; Bridget S Gosis; Stephanie N Regan; Chad A Cowan; Daniel J Rader; Kiran Musunuru
Journal:  Circ Res       Date:  2014-06-10       Impact factor: 17.367

8.  Rapid modelling of cooperating genetic events in cancer through somatic genome editing.

Authors:  Francisco J Sánchez-Rivera; Thales Papagiannakopoulos; Rodrigo Romero; Tuomas Tammela; Matthew R Bauer; Arjun Bhutkar; Nikhil S Joshi; Lakshmipriya Subbaraj; Roderick T Bronson; Wen Xue; Tyler Jacks
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

Review 9.  Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing.

Authors:  Xiya Zhang; Tao Li; Jianping Ou; Junjiu Huang; Puping Liang
Journal:  Protein Cell       Date:  2021-05-04       Impact factor: 14.870

10.  Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia.

Authors:  Francis P Pankowicz; Mercedes Barzi; Xavier Legras; Leroy Hubert; Tian Mi; Julie A Tomolonis; Milan Ravishankar; Qin Sun; Diane Yang; Malgorzata Borowiak; Pavel Sumazin; Sarah H Elsea; Beatrice Bissig-Choisat; Karl-Dimiter Bissig
Journal:  Nat Commun       Date:  2016-08-30       Impact factor: 14.919

View more
  1 in total

1.  Gene editing: from technologies to applications in research and beyond.

Authors:  Wensheng Wei; Caixia Gao
Journal:  Sci China Life Sci       Date:  2022-03-10       Impact factor: 10.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.